PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
14-Nov-2024 AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease AC Immune
14-Nov-2024 SEKISUI Completes £15.7 Million Expansion in cGMP Biopharma CDMO Capacity SEKISUI
14-Nov-2024 Terumo Blood and Cell Technologies Unlocks New Chapter of Localization in China to Facilitate Blood and Cell Treatment Options for Patients Terumo Blood and Cell Technologies
14-Nov-2024 Marinomed Biotech AG announces unanimous approval of the restructuring plan by creditors Marinomed Biotech AG
14-Nov-2024 In full bloom: WEECO Pharma boosts SYNBIOTIC's sales SYNBIOTIC SE
14-Nov-2024 Xeltis announces FDA Breakthrough Device Designation for aXessTM and first patient treated in US pivotal trial Xeltis
14-Nov-2024 Actimed Therapeutics Announces Professor David Ebsworth to Become Executive Chairman Actimed Therapeutics
14-Nov-2024 Syncona launches new portfolio company Slingshot, the Syncona Accelerator Syncona Limited
14-Nov-2024 Waters Corporation Opens State-of-the-Art Precision Manufacturing Facility in Longbridge, UK Waters Corporation
14-Nov-2024 London #1 in Europe for Life Sciences London & Partners
14-Nov-2024 Biotest increases revenues in the first 9 months by 4.5% to Euro 523 million Biotest AG
14-Nov-2024 Biotest AG: Biotest corrects forecast for revenue, cash flow and ROCE – EBIT guidance unchanged Biotest AG
14-Nov-2024 Eckert & Ziegler Continues on Growth Path with Strong 9-Month Results in 2024 Eckert & Ziegler SE
14-Nov-2024 PharmaSGP with strong revenues growth in 9M 2024 – revenues forecast for FY 2024 raised  PharmaSGP Holding SE
14-Nov-2024 Dermapharm Holding SE posts strong results for Q3 2024, Arkopharma (France) back above prior-year EBITDA levels for first time Dermapharm Holding SE
14-Nov-2024 Curatis wird für C-PTBE-01 in den USA eine Biologic License beantragen - damit erhöht sich die Dauer des Marktschutzes in den USA markant im Falle einer Zulassung Curatis Holding AG
13-Nov-2024 Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax ABIVAX
13-Nov-2024 AC Immune to Present at the Jefferies 2024 London Healthcare Conference AC Immune
13-Nov-2024 Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet Gastroenterology & Hepatology Immunic AG
13-Nov-2024 Sanofi wins appeal against negative Final Draft Guidance for its standard-of-care multiple myeloma combination therapy opening the door for a third NICE Committee Meeting Sanofi